Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen McShane

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
Swiss Medical Weekly|January 20, 2009
Vaccine strategies against tuberculosisHelen McShane
The Journal of Infectious Diseases|August 21, 2023
Improving Tuberculosis Vaccine Trial Efficiency: A Tough Nut to CrackHelen McShane
Expert Review of Vaccines|November 24, 2018
Current approaches toward identifying a correlate of immune protection from tuberculosisIman Satti, Helen McShane
Microbes and Infection|May 14, 2005
Prime-boost immunisation strategies for tuberculosisHelen McShane, Adrian Hill
ALTEX|September 27, 2016
Replacing, reducing and refining the use of animals in tuberculosis vaccine researchRachel Tanner, Helen McShane
Expert Review of Vaccines|May 25, 2011
Tuberculosis vaccines in clinical trialsRosalind Rowland, Helen McShane
Expert Review of Vaccines|March 25, 2016
Why don't we have an effective tuberculosis vaccine yet?Tamara Davenne, Helen McShane
Seminars in Immunopathology|March 20, 2020
Towards new TB vaccinesBenedict Brazier, Helen McShane
Tuberculosis (Edinburgh, Scotland)|December 28, 2013
A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy dataHelen McShane, Ann Williams
Expert Opinion on Emerging Drugs|April 26, 2006
Tuberculosis vaccines: current status and future prospectsHelen Fletcher, Helen McShane
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
Swiss Medical Weekly|January 20, 2009
Vaccine strategies against tuberculosisHelen McShane
The Journal of Infectious Diseases|August 21, 2023
Improving Tuberculosis Vaccine Trial Efficiency: A Tough Nut to CrackHelen McShane
Expert Review of Vaccines|November 24, 2018
Current approaches toward identifying a correlate of immune protection from tuberculosisIman Satti, Helen McShane
Microbes and Infection|May 14, 2005
Prime-boost immunisation strategies for tuberculosisHelen McShane, Adrian Hill
ALTEX|September 27, 2016
Replacing, reducing and refining the use of animals in tuberculosis vaccine researchRachel Tanner, Helen McShane
Expert Review of Vaccines|May 25, 2011
Tuberculosis vaccines in clinical trialsRosalind Rowland, Helen McShane
Expert Review of Vaccines|March 25, 2016
Why don't we have an effective tuberculosis vaccine yet?Tamara Davenne, Helen McShane
Seminars in Immunopathology|March 20, 2020
Towards new TB vaccinesBenedict Brazier, Helen McShane
Tuberculosis (Edinburgh, Scotland)|December 28, 2013
A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy dataHelen McShane, Ann Williams
Expert Opinion on Emerging Drugs|April 26, 2006
Tuberculosis vaccines: current status and future prospectsHelen Fletcher, Helen McShane
Pageof 22